Market Overview:
The global HIV diagnosis market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of HIV/AIDS, technological advancements in diagnostic tests, and growing awareness about HIV/AIDS. The global HIV diagnosis market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibody tests, viral load tests, CD4 tests, early infant diagnosis (EID) tests,, and viral identification (VI) tests. The antibody test segment dominates the global HIV diagnosis market owing to its high accuracy and reliability for diagnosing HIV infection.
Product Definition:
A diagnosis of HIV infection is made when a person has certain signs and symptoms and tests positive for the presence of HIV antibodies. The diagnosis confirms that a person is infected with HIV, the virus that causes AIDS.
Antibody Tests:
Antibody tests are used for the detection of antibodies in the blood. These tests are also known as immunoassays or serological testing. The main function of these antibody tests is to identify an autoimmune disease by measuring and identifying a certain type of antibody produced in response to the disease-causing agent (in this case, HIV). An increase in awareness about HIV infection and its prevention measures has led to a rise in demand for these types of antibody tests over time.
Viral Load Tests:
Viral load tests are used for measuring the amount of HIV in the blood. These tests are also known as Antibody-Dependent Cellular Immunotherapy (ADCIT) test. It is a diagnostic procedure that involves testing of blood for the presence of virus using an antibody-dependent cellular immunoassay technique.
Application Insights:
Based on application, the global HIV diagnosis market is segmented into diagnostic laboratories, hospitals, blood banks and other settings (hospitals and others). The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a large number of factors such as high patient load due to late diagnosis coupled with rising prevalence. Moreover, an increase in government initiatives for early diagnosis at the domestic level has also positively influenced growth. For instance, Ministry of Health & Family Welfare (MOHFW) guidelines have recommended that every district should have a laboratory that provides rapid testing for HIV-1 infection so that people living with diagnosed but undiagnosed HIV can get appropriate medical care quickly. Such initiatives are expected to further fuel demand over the forecast period from 2018 to 2030.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high awareness levels regarding early diagnosis are some factors driving the growth of this region. Moreover, government initiatives to control the spread of HIV are also contributing towards regional growth. For instance, in 2014, CDC launched a national public health action campaign to prevent mother-to-child transmission (PMTCT) through antiretroviral therapy (ART).
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence levels.
Growth Factors:
- Increasing incidence of HIV/AIDS: The global incidence of HIV is increasing at an alarming rate. According to the World Health Organization (WHO), around 36 million people were living with HIV in 2015 and 1.8 million people died from AIDS-related causes that year. This number is only expected to grow in the coming years, providing a major growth driver for the HIV diagnosis market.
- Advances in diagnostic technologies: The development of novel diagnostic technologies has helped improve the accuracy and speed of diagnosing HIV infections, thus driving market growth. For instance, recent advances in molecular diagnostics have made it possible to detect viral RNA directly from patient samples, thus allowing for earlier diagnosis and treatment of patients infected with HIV virus variants that are resistant to currently available drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV Diagnosis Market Research Report
By Type
Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification
By Application
Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Others
By Companies
Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Thermo Fisher, Merck, Becton, Dickinson, Hologic, Abbott, Bio-Rad Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global HIV Diagnosis Market Report Segments:
The global HIV Diagnosis market is segmented on the basis of:
Types
Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthineers
- Roche Diagnostics
- Abbott Laboratories
- Beckman Coulter
- Thermo Fisher
- Merck
- Becton, Dickinson
- Hologic
- Abbott
- Bio-Rad Laboratories
Highlights of The HIV Diagnosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody Tests
- Viral Load Tests
- CD4 Tests
- Tests for Early Infant Diagnosis
- Tests for Viral Identification
- By Application:
- Diagnostic Laboratories
- Hospitals
- Blood Banks
- Home Care Settings
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HIV diagnosis is the process of confirming that a person has HIV. This can be done through tests that look for the virus in a person's blood or other body fluids.
Some of the major companies in the hiv diagnosis market are Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Thermo Fisher, Merck, Becton, Dickinson, Hologic, Abbott, Bio-Rad Laboratories.
The hiv diagnosis market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HIV Diagnosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HIV Diagnosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HIV Diagnosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HIV Diagnosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HIV Diagnosis Market Size & Forecast, 2020-2028
4.5.1 HIV Diagnosis Market Size and Y-o-Y Growth
4.5.2 HIV Diagnosis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibody Tests
5.2.2 Viral Load Tests
5.2.3 CD4 Tests
5.2.4 Tests for Early Infant Diagnosis
5.2.5 Tests for Viral Identification
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostic Laboratories
6.2.2 Hospitals
6.2.3 Blood Banks
6.2.4 Home Care Settings
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HIV Diagnosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HIV Diagnosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibody Tests
9.6.2 Viral Load Tests
9.6.3 CD4 Tests
9.6.4 Tests for Early Infant Diagnosis
9.6.5 Tests for Viral Identification
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostic Laboratories
9.10.2 Hospitals
9.10.3 Blood Banks
9.10.4 Home Care Settings
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibody Tests
10.6.2 Viral Load Tests
10.6.3 CD4 Tests
10.6.4 Tests for Early Infant Diagnosis
10.6.5 Tests for Viral Identification
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostic Laboratories
10.10.2 Hospitals
10.10.3 Blood Banks
10.10.4 Home Care Settings
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibody Tests
11.6.2 Viral Load Tests
11.6.3 CD4 Tests
11.6.4 Tests for Early Infant Diagnosis
11.6.5 Tests for Viral Identification
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostic Laboratories
11.10.2 Hospitals
11.10.3 Blood Banks
11.10.4 Home Care Settings
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibody Tests
12.6.2 Viral Load Tests
12.6.3 CD4 Tests
12.6.4 Tests for Early Infant Diagnosis
12.6.5 Tests for Viral Identification
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostic Laboratories
12.10.2 Hospitals
12.10.3 Blood Banks
12.10.4 Home Care Settings
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibody Tests
13.6.2 Viral Load Tests
13.6.3 CD4 Tests
13.6.4 Tests for Early Infant Diagnosis
13.6.5 Tests for Viral Identification
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostic Laboratories
13.10.2 Hospitals
13.10.3 Blood Banks
13.10.4 Home Care Settings
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HIV Diagnosis Market: Competitive Dashboard
14.2 Global HIV Diagnosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthineers
14.3.2 Roche Diagnostics
14.3.3 Abbott Laboratories
14.3.4 Beckman Coulter
14.3.5 Thermo Fisher
14.3.6 Merck
14.3.7 Becton, Dickinson
14.3.8 Hologic
14.3.9 Abbott
14.3.10 Bio-Rad Laboratories
